GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Fisher & Paykel Healthcare Corp Ltd (OTCPK:FSPKF) » Definitions » Tax Rate %

FSPKF (Fisher & Paykel Healthcare) Tax Rate % : 25.78% (As of Sep. 2024)


View and export this data going back to 2009. Start your Free Trial

What is Fisher & Paykel Healthcare Tax Rate %?

Tax Rate % is calculated as Tax Expense divided by its Pre-Tax Income. Fisher & Paykel Healthcare's Tax Expense for the six months ended in Sep. 2024 was $33 Mil. Fisher & Paykel Healthcare's Pre-Tax Income for the six months ended in Sep. 2024 was $128 Mil. Therefore, Fisher & Paykel Healthcare's Tax Rate % for the quarter that ended in Sep. 2024 was 25.78%.

Fisher & Paykel Healthcare Tax Rate % Historical Data

The historical data trend for Fisher & Paykel Healthcare's Tax Rate % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fisher & Paykel Healthcare Tax Rate % Chart

Fisher & Paykel Healthcare Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Tax Rate %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 22.46 27.01 25.25 23.69 43.74

Fisher & Paykel Healthcare Semi-Annual Data
Mar15 Sep15 Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24
Tax Rate % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 16.10 27.75 23.68 73.40 25.78

Fisher & Paykel Healthcare Tax Rate % Calculation

Tax Rate % is the ratio of tax expense divided by pretax income, usually presented in percent.

Fisher & Paykel Healthcare's Tax Rate % for the fiscal year that ended in Mar. 2024 is calculated as

Tax Rate %=Tax Expense (A: Mar. 2024 )/Pre-Tax Income (A: Mar. 2024 )
=62.713/143.37
=43.74 %

Fisher & Paykel Healthcare's Tax Rate % for the quarter that ended in Sep. 2024 is calculated as

Tax Rate %=Tax Expense (Q: Sep. 2024 )/Pre-Tax Income (Q: Sep. 2024 )
=33.105/128.438
=25.78 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Fisher & Paykel Healthcare Tax Rate % Related Terms

Thank you for viewing the detailed overview of Fisher & Paykel Healthcare's Tax Rate % provided by GuruFocus.com. Please click on the following links to see related term pages.

Fisher & Paykel Healthcare Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Fisher & Paykel Healthcare Corp Ltd (OTCPK:FSPKF) » Definitions » Tax Rate %
Comparable Companies
ASX:AOK ASX:BRK ASX:CTP ASX:SHE ASX:CUE ASX:PVE ASX:ECH ASX:MAY ASX:JPR ASX:BAS ISRG XPAR:EL BDX TSE:7741 XSWX:ALC RMD TSE:4543 OCSE:COLO B WST COO
Traded in Other Exchanges
FPH:New Zealand FPLB:Germany FPLB:Germany FPH:Australia
Address
15 Maurice Paykel Place, East Tamaki, Auckland, NTL, NZL, 2013
Website
https://www.fphcare.com
Fisher & Paykel Healthcare is one of the three largest respiratory care device companies globally. It is the market leader in hospital use humidifiers, masks and related consumables and the number three player in the at-home treatment of sleep apnea using respiratory devices. Both the hospital and homecare markets for respiratory devices are growing strongly in the developed markets in which Fisher & Paykel has a presence. The company earns 42% of its revenue in the US, 32% in Europe, 18% in Asia-Pacific and the remaining 8% in emerging markets. Fisher conducts its own R&D and has thousands of patents and pending applications. It manufactures in New Zealand and Mexico and has a multichannel distribution model.